Ana M. Walton, ODS-C (@anawaltonods) 's Twitter Profile
Ana M. Walton, ODS-C

@anawaltonods

Oncology Data Specialist-Certified | Cancer Registry Data | AI KACI NeuralFrame | METRIQ | CRStar | Epic | Cerner | ONCOLOG | baptisthealthsystem.com

ID: 1813236643177881600

calendar_today16-07-2024 15:38:40

650 Tweet

453 Followers

1,1K Following

Dr Joseph McCollom DO (@realbowtiedoc) 's Twitter Profile Photo

“I shouldn't be here” It's not that I don't feel like I belong here at #GI24 These are my people It's more of a recognition of my personal statistics. A thread 1/7 🧵

“I shouldn't be here”

It's not that I don't feel like I belong here at #GI24
These are my people
It's more of a recognition of my personal statistics. A thread 1/7 🧵
Common Sense Oncology (@csoncol) 's Twitter Profile Photo

It’s time for the second annual class of CSO Fellows! Calling all early career medical oncologists! Now accepting applications for the Common Sense Oncology Fellowship in Cancer Policy Queen's University. Apply today to help build a better cancer care system. Read the full posting

It’s time for the second annual class of CSO Fellows! 

Calling all early career medical oncologists! Now accepting applications for the Common Sense Oncology Fellowship in Cancer Policy <a href="/queensu/">Queen's University</a>. 

Apply today to help build a better cancer care system. Read the full posting
Erman Akkus (@erman_akkus) 's Twitter Profile Photo

⚡️Upper GI- Mini oral (Day-4) #ESMO24 ESMO - Eur. Oncology ➡️ Response to neoadjuvant FLOT to decide adjuvant FLOT? ✅Only partial responders benefit from adjuvant treatment ❗️ ❗️Prospective clinical trials is needed OncoAlert OncLive.com #medx #cancer #oncology

⚡️Upper GI- Mini oral (Day-4) #ESMO24 <a href="/myESMO/">ESMO - Eur. Oncology</a> 

➡️ Response to neoadjuvant FLOT to decide adjuvant FLOT?
✅Only partial responders benefit from adjuvant treatment ❗️
❗️Prospective clinical trials is needed

<a href="/OncoAlert/">OncoAlert</a> <a href="/OncLive/">OncLive.com</a> #medx #cancer #oncology
Ana M. Walton, ODS-C (@anawaltonods) 's Twitter Profile Photo

✨Recent AI breakthroughs are transforming cancer treatment. Johns Hopkins' BigMHC uses deep learning to identify cancer cell proteins and predict immune responses, paving the way for personalized immunotherapies over traditional treatments like chemotherapy. MIT's Sybil AI tool

✨Recent AI breakthroughs are transforming cancer treatment. Johns Hopkins' BigMHC uses deep learning to identify cancer cell proteins and predict immune responses, paving the way for personalized immunotherapies over traditional treatments like chemotherapy. MIT's Sybil AI tool
Ana M. Walton, ODS-C (@anawaltonods) 's Twitter Profile Photo

🚨 ATTENTION CALLING 📢ALL PhD STUDENTS & POSTDOCS ‼️‼️ 🚨 🧪👨‍🔬👩‍🔬🥽🔬🧬🦠🫁 📢Newly opened lab at the Institute of Human Biology of Roche in Basel working on human lung, liver & gut organoids 👇👇👇 ✅Send email + CV + motivation letter to [email protected] with header

Ana M. Walton, ODS-C (@anawaltonods) 's Twitter Profile Photo

💻⌨️🖱️ Cancer Patient Resource Websites 🏆 The websites listed below are valuable sources of cancer information for patients and their families 👀 👇👇👇 THESE ARE THE MOST VALUABLE CANCER INFORMATION LINKS YOU WILL NEED👈 💡 American Cancer Society Organization providing

Ana M. Walton, ODS-C (@anawaltonods) 's Twitter Profile Photo

THE ROLE OF HORMONE THERAPY IN BREAST CANCER 💊💊💊💊 Hormone therapy is used to treat hormone receptor-positive breast cancer, where cancer cells have proteins that bind to estrogen or progesterone, promoting growth. The therapy works by either blocking estrogen production or

THE ROLE OF HORMONE THERAPY IN BREAST CANCER 💊💊💊💊

Hormone therapy is used to treat hormone receptor-positive breast cancer, where cancer cells have proteins that bind to estrogen or progesterone, promoting growth. The therapy works by either blocking estrogen production or
Ana M. Walton, ODS-C (@anawaltonods) 's Twitter Profile Photo

📢ADEPT TRIAL 👇👇👇 💊💊💊SINGLE ARM PHASE II STUDY OF ADJUVANT ENDOCRINE THERAPY, PERTUZUMAB, & TRASTUZUMAB FOR PATIENTS WITH STAGE I HORMONE RECEPTOR-POSITIVE, HER2-POSITIVE BREAST CANCER 🧬♀️ ♋️ 📌 Dana-Farber’s Breast Oncology Center is leading the ADEPT study, exploring a non-chemotherapy

Common Sense Oncology (@csoncol) 's Twitter Profile Photo

Only 1 week remaining. Apply today to work with an amazing group of global leaders dedicated to improving outcomes that matter in cancer care!

Ana M. Walton, ODS-C (@anawaltonods) 's Twitter Profile Photo

🩺🥼👩‍⚕️Dr. Cornedine Jannette de Gooijer presented findings 📊📝from the FLORA study🔎📈📉 📍The study focused on 🥈second-line 💉🧪platinum-based pemetrexed in pleural 🫁mesothelioma patients. 📍Patients had previously progressed ⤴️on 💉🧪nivolumab and ipilimumab. 📍Some

🩺🥼👩‍⚕️Dr. Cornedine Jannette de Gooijer presented findings 📊📝from the FLORA study🔎📈📉

📍The study focused on 🥈second-line 💉🧪platinum-based pemetrexed in pleural 🫁mesothelioma patients.

📍Patients had previously progressed ⤴️on 💉🧪nivolumab and ipilimumab.

📍Some
Ana M. Walton, ODS-C (@anawaltonods) 's Twitter Profile Photo

This is so satisfying to watch... Macrophage eating Cancer Cell 3D Animation | Phagocytosis | Immunology @... youtube.com/shorts/vGuqcpT… via YouTube

Ana M. Walton, ODS-C (@anawaltonods) 's Twitter Profile Photo

Watch a cancer cell die live 🔬☠️⚰️ Immune Cells vs. Cancer: Watch the Battle Unfold Under the Microscope. youtube.com/shorts/iKh0sIZ… via YouTube